Oui, l'âge peut affecter l'expression de Wnt-5a et son rôle dans diverses pathologies.
ÂgeExpression génétique
#3
Le tabagisme affecte-t-il Wnt-5a ?
Oui, le tabagisme peut altérer l'expression de Wnt-5a, augmentant le risque de cancer.
TabagismeRisque de cancer
#4
Y a-t-il un lien entre l'alimentation et Wnt-5a ?
Oui, une alimentation riche en graisses peut influencer négativement l'expression de Wnt-5a.
AlimentationGraisses alimentaires
#5
Le stress chronique impacte-t-il Wnt-5a ?
Oui, le stress chronique peut perturber la régulation de Wnt-5a, augmentant les risques de maladies.
Stress chroniqueRégulation hormonale
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Protéine Wnt-5a : Questions médicales les plus fréquentes",
"headline": "Protéine Wnt-5a : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Protéine Wnt-5a : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-28",
"dateModified": "2025-04-23",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Protéine Wnt-5a"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines de type Wingless",
"url": "https://questionsmedicales.fr/mesh/D051153",
"about": {
"@type": "MedicalCondition",
"name": "Protéines de type Wingless",
"code": {
"@type": "MedicalCode",
"code": "D051153",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.984"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Protéine Wnt-5a",
"alternateName": "Wnt-5a Protein",
"code": {
"@type": "MedicalCode",
"code": "D000071818",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Soon B Hwang",
"url": "https://questionsmedicales.fr/author/Soon%20B%20Hwang",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of RNA Viral Diseases, Korea Zoonosis Research Institute, Chonbuk National University, Iksan, South Korea sbhwang@jbnu.ac.kr."
}
},
{
"@type": "Person",
"name": "Rui Zhou",
"url": "https://questionsmedicales.fr/author/Rui%20Zhou",
"affiliation": {
"@type": "Organization",
"name": "Group of Cell Motility and Muscle Contraction, State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China."
}
},
{
"@type": "Person",
"name": "Xiang-Dong Li",
"url": "https://questionsmedicales.fr/author/Xiang-Dong%20Li",
"affiliation": {
"@type": "Organization",
"name": "Group of Cell Motility and Muscle Contraction, State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China lixd@ioz.ac.cn."
}
},
{
"@type": "Person",
"name": "Richa Mishra",
"url": "https://questionsmedicales.fr/author/Richa%20Mishra",
"affiliation": {
"@type": "Organization",
"name": "Chemical Biology Laboratory, School of Basic Sciences, Indian Institute of Technology Bhubaneswar, Bhubaneswar, Odisha, India."
}
},
{
"@type": "Person",
"name": "Soumendra Rana",
"url": "https://questionsmedicales.fr/author/Soumendra%20Rana",
"affiliation": {
"@type": "Organization",
"name": "Chemical Biology Laboratory, School of Basic Sciences, Indian Institute of Technology Bhubaneswar, Bhubaneswar, Odisha, India."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Differentially expressed transcript isoforms associate with resistance to tuberculin skin test and interferon gamma release assay conversion.",
"datePublished": "2023-04-14",
"url": "https://questionsmedicales.fr/article/37058459",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0284498"
}
},
{
"@type": "ScholarlyArticle",
"name": "Monocyte Transcriptional Responses to Mycobacterium tuberculosis Associate with Resistance to Tuberculin Skin Test and Interferon Gamma Release Assay Conversion.",
"datePublished": "2022-06-13",
"url": "https://questionsmedicales.fr/article/35695527",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1128/msphere.00159-22"
}
},
{
"@type": "ScholarlyArticle",
"name": "Development of an Interferon-Gamma Release Assay (IGRA) to Aid Diagnosis of Histoplasmosis.",
"datePublished": "2022-10-03",
"url": "https://questionsmedicales.fr/article/36190260",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1128/jcm.01128-22"
}
},
{
"@type": "ScholarlyArticle",
"name": "Serial testing of latent tuberculosis infection in patients with diabetes mellitus using interferon-gamma release assay, tuberculin skin test, and creation tuberculin skin test.",
"datePublished": "2022-12-01",
"url": "https://questionsmedicales.fr/article/36530654",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fpubh.2022.1025550"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prevalence of latent Mycobacterium tuberculosis infection in hematopoietic stem cell transplantation comparing tuberculin skin test and interferon-gamma release assay.",
"datePublished": "2023-05-01",
"url": "https://questionsmedicales.fr/article/37126131",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10096-023-04613-w"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines et peptides de signalisation intercellulaire",
"item": "https://questionsmedicales.fr/mesh/D036341"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines de type Wingless",
"item": "https://questionsmedicales.fr/mesh/D051153"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protéine Wnt-5a",
"item": "https://questionsmedicales.fr/mesh/D000071818"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Protéine Wnt-5a - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Protéine Wnt-5a",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-05",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Protéine Wnt-5a",
"description": "Comment diagnostiquer une anomalie de Wnt-5a ?\nQuels tests sont utilisés pour mesurer Wnt-5a ?\nWnt-5a est-il lié à des maladies spécifiques ?\nPeut-on détecter Wnt-5a dans le sang ?\nQuels biomarqueurs sont associés à Wnt-5a ?",
"url": "https://questionsmedicales.fr/mesh/D000071818?mesh_terms=Interferon-gamma+Release+Tests#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Protéine Wnt-5a",
"description": "Quels symptômes sont liés à une dysrégulation de Wnt-5a ?\nWnt-5a influence-t-il le cancer ?\nY a-t-il des signes cliniques de dysfonction de Wnt-5a ?\nWnt-5a affecte-t-il le système nerveux ?\nQuels effets sur la peau sont liés à Wnt-5a ?",
"url": "https://questionsmedicales.fr/mesh/D000071818?mesh_terms=Interferon-gamma+Release+Tests#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Protéine Wnt-5a",
"description": "Peut-on prévenir les anomalies de Wnt-5a ?\nY a-t-il des facteurs environnementaux affectant Wnt-5a ?\nComment le mode de vie influence-t-il Wnt-5a ?\nLes suppléments nutritionnels aident-ils Wnt-5a ?\nLa gestion du stress influence-t-elle Wnt-5a ?",
"url": "https://questionsmedicales.fr/mesh/D000071818?mesh_terms=Interferon-gamma+Release+Tests#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Protéine Wnt-5a",
"description": "Comment traiter les anomalies de Wnt-5a ?\nY a-t-il des médicaments ciblant Wnt-5a ?\nLa thérapie génique peut-elle aider Wnt-5a ?\nQuels traitements sont efficaces contre le cancer lié à Wnt-5a ?\nDes essais cliniques existent-ils pour Wnt-5a ?",
"url": "https://questionsmedicales.fr/mesh/D000071818?mesh_terms=Interferon-gamma+Release+Tests#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Protéine Wnt-5a",
"description": "Quelles complications sont liées à Wnt-5a ?\nWnt-5a peut-il causer des troubles métaboliques ?\nY a-t-il des risques de récidive de cancer avec Wnt-5a ?\nWnt-5a influence-t-il la réponse immunitaire ?\nDes complications neurologiques sont-elles possibles avec Wnt-5a ?",
"url": "https://questionsmedicales.fr/mesh/D000071818?mesh_terms=Interferon-gamma+Release+Tests#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Protéine Wnt-5a",
"description": "Quels sont les facteurs de risque pour Wnt-5a ?\nL'âge influence-t-il Wnt-5a ?\nLe tabagisme affecte-t-il Wnt-5a ?\nY a-t-il un lien entre l'alimentation et Wnt-5a ?\nLe stress chronique impacte-t-il Wnt-5a ?",
"url": "https://questionsmedicales.fr/mesh/D000071818?mesh_terms=Interferon-gamma+Release+Tests#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une anomalie de Wnt-5a ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques et des analyses de tissus peuvent être utilisés pour évaluer les niveaux de Wnt-5a."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour mesurer Wnt-5a ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des dosages ELISA et des techniques de Western blot sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Wnt-5a est-il lié à des maladies spécifiques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies de Wnt-5a sont associées à des cancers et des maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Peut-on détecter Wnt-5a dans le sang ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux de Wnt-5a peuvent être mesurés dans le sérum sanguin."
}
},
{
"@type": "Question",
"name": "Quels biomarqueurs sont associés à Wnt-5a ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "D'autres protéines de la voie Wnt, comme Wnt-1 et β-caténine, peuvent être des biomarqueurs."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à une dysrégulation de Wnt-5a ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies de développement, des troubles immunitaires et des cancers peuvent survenir."
}
},
{
"@type": "Question",
"name": "Wnt-5a influence-t-il le cancer ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une expression anormale de Wnt-5a est liée à la progression de certains cancers."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes cliniques de dysfonction de Wnt-5a ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des malformations congénitales et des troubles de la croissance peuvent être observés."
}
},
{
"@type": "Question",
"name": "Wnt-5a affecte-t-il le système nerveux ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, Wnt-5a joue un rôle dans le développement neuronal et peut affecter la neurogenèse."
}
},
{
"@type": "Question",
"name": "Quels effets sur la peau sont liés à Wnt-5a ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies de Wnt-5a peuvent entraîner des troubles cutanés et des cancers de la peau."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les anomalies de Wnt-5a ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par une bonne santé maternelle et des soins prénatals appropriés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs environnementaux affectant Wnt-5a ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des toxines et à des perturbateurs endocriniens peut influencer Wnt-5a."
}
},
{
"@type": "Question",
"name": "Comment le mode de vie influence-t-il Wnt-5a ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, incluant une alimentation équilibrée, peut soutenir la régulation de Wnt-5a."
}
},
{
"@type": "Question",
"name": "Les suppléments nutritionnels aident-ils Wnt-5a ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains suppléments, comme les acides gras oméga-3, peuvent moduler l'expression de Wnt-5a."
}
},
{
"@type": "Question",
"name": "La gestion du stress influence-t-elle Wnt-5a ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la gestion du stress peut avoir un impact positif sur la régulation de Wnt-5a."
}
},
{
"@type": "Question",
"name": "Comment traiter les anomalies de Wnt-5a ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies ciblées et des traitements immunologiques peuvent être envisagés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des médicaments ciblant Wnt-5a ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des inhibiteurs de la voie Wnt sont en développement pour traiter certains cancers."
}
},
{
"@type": "Question",
"name": "La thérapie génique peut-elle aider Wnt-5a ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est explorée pour corriger les anomalies de Wnt-5a dans certaines conditions."
}
},
{
"@type": "Question",
"name": "Quels traitements sont efficaces contre le cancer lié à Wnt-5a ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements combinés de chimiothérapie et d'immunothérapie montrent des résultats prometteurs."
}
},
{
"@type": "Question",
"name": "Des essais cliniques existent-ils pour Wnt-5a ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, plusieurs essais cliniques évaluent des traitements ciblant la voie Wnt-5a."
}
},
{
"@type": "Question",
"name": "Quelles complications sont liées à Wnt-5a ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des malformations congénitales et des cancers avancés."
}
},
{
"@type": "Question",
"name": "Wnt-5a peut-il causer des troubles métaboliques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une dysrégulation de Wnt-5a peut contribuer à des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de récidive de cancer avec Wnt-5a ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une expression anormale de Wnt-5a est associée à un risque accru de récidive."
}
},
{
"@type": "Question",
"name": "Wnt-5a influence-t-il la réponse immunitaire ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, Wnt-5a peut moduler la réponse immunitaire, affectant la susceptibilité aux infections."
}
},
{
"@type": "Question",
"name": "Des complications neurologiques sont-elles possibles avec Wnt-5a ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies de Wnt-5a peuvent entraîner des complications neurologiques."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour Wnt-5a ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des prédispositions génétiques et des expositions environnementales."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il Wnt-5a ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'âge peut affecter l'expression de Wnt-5a et son rôle dans diverses pathologies."
}
},
{
"@type": "Question",
"name": "Le tabagisme affecte-t-il Wnt-5a ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut altérer l'expression de Wnt-5a, augmentant le risque de cancer."
}
},
{
"@type": "Question",
"name": "Y a-t-il un lien entre l'alimentation et Wnt-5a ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en graisses peut influencer négativement l'expression de Wnt-5a."
}
},
{
"@type": "Question",
"name": "Le stress chronique impacte-t-il Wnt-5a ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut perturber la régulation de Wnt-5a, augmentant les risques de maladies."
}
}
]
}
]
}
Group of Cell Motility and Muscle Contraction, State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
University of Chinese Academy of Sciences, Beijing 100049, China.
Group of Cell Motility and Muscle Contraction, State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China lixd@ioz.ac.cn.
University of Chinese Academy of Sciences, Beijing 100049, China.
Departamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile; Centro de Excelencia en Biomedicina de Magallanes (CEBIMA), Escuela de Medicina, Universidad de Magallanes, Punta Arenas, Chile. Electronic address: ninestrosa@bio.puc.cl.
Group of Cell Motility and Muscle Contraction, State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
Group of Cell Motility and Muscle Contraction, State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
Group of Cell Motility and Muscle Contraction, State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
Group of Cell Motility and Muscle Contraction, State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
University of Chinese Academy of Sciences, Beijing, China.
A mechanistic understanding of uncommon immune outcomes such as resistance to infection has led to the development of novel therapies. Using gene level analytic methods, we previously found distinct m...
Using transcript isoform analyses, we aimed to identify novel RSTR-associated genes hypothesizing that previous gene-level differential expression analysis obscures isoform-specific differences that c...
Monocytes from 49 RSTR versus 52 subjects with latent Mtb infection (LTBI) were infected with M. tuberculosis (H37Rv) or left unstimulated (media) prior to RNA isolation and sequencing. RSTR-associate...
We identified 81 differentially expressed transcripts (DETs) in 70 genes (FDR <0.05) comparing RSTR and LTBI phenotypes with the majority (n = 79 DETs) identified under Mtb-stimulated conditions. Seve...
Transcript isoform-specific analyses identify transcriptional associations, such as those associated with resistance to TST/IGRA conversion, that are obscured when using gene-level approaches. These f...
Heavy exposure to Mycobacterium tuberculosis, the etiologic agent of tuberculosis (TB) and among the top infectious killers worldwide, results in infection that is cleared, contained, or progresses to...
Establishing diagnosis of latent and active histoplasmosis is challenging. Interferon gamma-release assays (IGRAs) may provide evidence of latent and active infection. An enzyme-linked immunospot (ELI...
Diabetes mellitus (DM) patients with latent tuberculosis infection (LTBI) have an increased risk of developing active tuberculosis (TB) due to impaired immunity. The performance of currently available...
A prospective study was conducted to investigate the status of LTBI in patients with confirmed T2DM. At the baseline survey, the prevalence of LTBI was tested using interferon-gamma release assay (IGR...
A total of 404 participants with T2DM were included in the study. At baseline, after excluding active TB, the prevalence of LTBI identified by TST (≥ 10 mm), C-TST (≥ 5 mm) and IGRA (≥ 0.35 IU/ml) wer...
In studied patients with T2DM, C-TST showed higher consistency with IGRA as compared to TST. The present of conversion observed in serial testing suggested that boosting effect of skin testing should ...
The aim of this study was to evaluate the prevalence of latent Mycobacterium tuberculosis infection in hematopoietic stem cell transplantation candidates, using tuberculin skin test and QuantiFERON-TB...
The interferon-gamma (IFN-γ) release assay (IGRA) is an important laboratory diagnosis for latent Mycobacterium tuberculosis (TB) infection. The TB-IGRA measures the release of IFN-γ from peripheral b...
We have analyzed the clinical data of 776 children who are underwent TB-IGRA testing in the Department of Allergy and Rheumatology of Guangzhou Women and Children's Medical Center from 2018 to 2020. T...
The TB Ag-NL levels were significantly higher in patients with active SLE than those in inactive SLE (p = 0.0002). The TB Ag-NL levels were positively correlated with the SLE disease activity index (S...
The detection of IFN-γ release levels by the TB-IGRA may be useful to assess SLE disease activity in pediatric patients with active SLE....
Although the Interferon Gamma Release Assays (IGRA) is often used to identify latent tuberculosis, it also plays a crucial role in diagnosing active extrapulmonary tuberculosis. Some studies have asse...
We searched PubMed, Embase, and Cochran databases. We obtained literature related to the diagnosis of OATB by IGRA, and the retrieval period was from the establishment of the database to June 2021. Th...
We included seven studies involving 643 subjects in diagnosing OATB by IGRA. The comprehensive sensitivity and specificity were 0.84 (95% CI, 0.70-0.92) and 0.78 (95% CI, 0.66-0.87), respectively. The...
In blood samples, the diagnostic accuracy of IGRAS is poor in patients with suspected OAT. We conclude that IGRA may not be appropriate for patients with OATB....
Latent tuberculosis is prevalent in HIV-infected people and has an impact on the progression of AIDS. The aim of this study is to match a more accurate IGRA method for the better detection of latent t...
Interferon-gamma release assays (IGRAs) are approved for children ≥2 years old to aid in diagnosis of Mycobacterium tuberculosis (TB) infection and disease. Tuberculin skin tests (TSTs) continue to be...
We performed a retrospective cohort study of IGRA use in patients <2 years old in 2 large Boston healthcare systems. The primary outcome was the proportion of valid versus invalid/indeterminate IGRA r...
A total of 321 IGRA results were analyzed; 308 tests (96%) were valid and 13 (4%) were invalid/indeterminate. Thirty-seven IGRAs were obtained in immunocompromised patients; the proportion of invalid/...
The high proportion of valid IGRA test results in patients <2 years of age in a low TB prevalence setting in combination with the known logistical and interpretation challenges associated with TSTs su...
To predict protective immunity to SARS-CoV-2, cellular immunity seems to be more sensitive than humoral immunity. Through an Interferon-Gamma (IFN-γ) Release Assay (IGRA), we show that, despite a mark...